Projected Income Statement: Pandox AB

Forecast Balance Sheet: Pandox AB

Forecast Balance Sheet - Pandox AB
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 31,030 35,464 34,857 37,413 51,860 48,246 48,496 48,650
Change - 14.29% -1.71% 7.33% 38.61% -6.97% 0.52% 0.32%
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Cash Flow Forecast: Pandox AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 531 898 2,375 1,024 1,087 1,407 1,248 1,271
Change - 69.11% 164.48% -56.88% 6.15% 29.45% -11.34% 1.87%
Free Cash Flow (FCF) 1 -1,091 740 712 802 2,014 12,610 1,184 1,642
Change - 167.83% -3.78% 12.64% 151.12% 526.12% -90.61% 38.74%
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Forecast Financial Ratios: Pandox AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 57.07% 58.44% 53.96% 55.51% 54.71% 61.44% 59.71% 59.64%
EBIT Margin (%) 47.97% 52.19% 53.44% 51.22% 53.37% 58.59% 57.1% 57.05%
EBT Margin (%) 27.07% 94.64% -7.26% 33.06% 51.49% 39.26% 37.16% 37.52%
Net margin (%) 18.64% 74.58% -8.54% 23.67% 42.03% 28.62% 28.68% 28.82%
FCF margin (%) -33.33% 13.09% 10.4% 11.24% 26.96% 146.64% 13.09% 17.74%
FCF / Net Income (%) -178.85% 17.55% -121.71% 47.48% 64.16% 512.46% 45.63% 61.54%

Profitability

        
ROA 0.93% 5.94% -0.79% 2.19% - - - -
ROE 2.49% 15.08% -1.94% 5.35% 9.33% 6.28% 5.44% 5.27%

Financial Health

        
Leverage (Debt/EBITDA) 16.61x 10.73x 9.43x 9.45x 12.69x 9.13x 8.98x 8.81x
Debt / Free cash flow -28.44x 47.92x 48.96x 46.65x 25.75x 3.83x 40.98x 29.63x

Capital Intensity

        
CAPEX / Current Assets (%) 16.22% 15.88% 34.68% 14.35% 14.55% 16.36% 13.8% 13.73%
CAPEX / EBITDA (%) 28.43% 27.18% 64.26% 25.85% 26.6% 26.63% 23.11% 23.02%
CAPEX / FCF (%) -48.67% 121.35% 333.57% 127.68% 53.97% 11.16% 105.41% 77.4%

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - 2.5 4 4.25 4.5 4.935 5.155 5.491
Change - - 60% 6.25% 5.88% 9.67% 4.45% 6.53%
Book Value Per Share 1 137.1 167.2 160.8 172.3 173.3 186.5 198.7 211
Change - 21.89% -3.77% 7.11% 0.6% 7.58% 6.57% 6.19%
EPS 1 3.32 22.94 -3.18 9.04 16.13 12.62 13.83 14.21
Change - 590.96% -113.86% 384.28% 78.43% -21.75% 9.58% 2.77%
Nbr of stocks (in thousands) 183,850 183,850 183,850 194,603 194,603 194,603 194,603 194,603
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK
Estimates
2026 *2027 *
P/E 13x 11.8x
PBR 0.88x 0.82x
EV / Sales 9.31x 8.88x
Yield 3.02% 3.15%

EPS & Dividend

EPS & Dividend - Pandox AB


Y-o-Y evolution of P/E

Valuation ratios - P/E - Pandox AB
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Pandox AB
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Pandox AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
163.60SEK
Average target price
202.60SEK
Spread / Average Target
+23.84%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Pandox AB